Menu Menu Menu Login Login Log in Search Search Search

Quantum Pharma plc (QP.) Ordinary 10p

Sell:81.75p Buy:82.00p 0 Change: No change  
Market closed Prices as at close on 20 October 2017 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation | Scheme of Arrangement

Quantum Pharma plc Ordinary 10p

Type:
Scheme of Arrangement
Shareholder action required:
Yes
Status:
Cash and shares due 14 Nov 2017
Details (last updated 5 Oct 2017)

The Boards of Quantum Pharma plc and Clinigen Group plc have announced that they have reached agreement on the terms of a recommended acquisition, by Clinigen Group plc, of Quantum Pharma plc. As a holder of Quantum Pharma plc Shares held within your Hargreaves Lansdown Account you have been offered 37p in cash and 0.0405 of a Clinigen Group plc Share for each Quantum Pharma plc Share held at the close of business on 30 October 2017.
The Scheme is subject to a General Meeting and Court Meeting both to be held on 23 October 2017. If you wish to register a vote before our noon Wednesday 18 October 2017 deadline, you can do so by selecting an option below.
If the Scheme is approved at a General Meeting and Court Meeting both to be held on 23 October 2017 and a Court Hearing on 31 October 2017 it will become effective on 1 November 2017 with the resulting Shares expected on or around 2 November 2017 and resulting cash expected on or around 14 November 2017.
Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:81.75p
Buy:82.00p
Change: No change  
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed Prices as at close on 20 October 2017 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation | Scheme of Arrangement

Quantum Pharma plc Ordinary 10p

Type:
Scheme of Arrangement
Shareholder action required:
Yes
Status:
Cash and shares due 14 Nov 2017
Details (last updated 5 Oct 2017)

The Boards of Quantum Pharma plc and Clinigen Group plc have announced that they have reached agreement on the terms of a recommended acquisition, by Clinigen Group plc, of Quantum Pharma plc. As a holder of Quantum Pharma plc Shares held within your Hargreaves Lansdown Account you have been offered 37p in cash and 0.0405 of a Clinigen Group plc Share for each Quantum Pharma plc Share held at the close of business on 30 October 2017.
The Scheme is subject to a General Meeting and Court Meeting both to be held on 23 October 2017. If you wish to register a vote before our noon Wednesday 18 October 2017 deadline, you can do so by selecting an option below.
If the Scheme is approved at a General Meeting and Court Meeting both to be held on 23 October 2017 and a Court Hearing on 31 October 2017 it will become effective on 1 November 2017 with the resulting Shares expected on or around 2 November 2017 and resulting cash expected on or around 14 November 2017.
Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Sell:81.75p
Buy:82.00p
Change: No change  
Market closed Prices as at close on 20 October 2017 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation | Scheme of Arrangement

Quantum Pharma plc Ordinary 10p

Type:
Scheme of Arrangement
Shareholder action required:
Yes
Status:
Cash and shares due 14 Nov 2017
Details (last updated 5 Oct 2017)

The Boards of Quantum Pharma plc and Clinigen Group plc have announced that they have reached agreement on the terms of a recommended acquisition, by Clinigen Group plc, of Quantum Pharma plc. As a holder of Quantum Pharma plc Shares held within your Hargreaves Lansdown Account you have been offered 37p in cash and 0.0405 of a Clinigen Group plc Share for each Quantum Pharma plc Share held at the close of business on 30 October 2017.
The Scheme is subject to a General Meeting and Court Meeting both to be held on 23 October 2017. If you wish to register a vote before our noon Wednesday 18 October 2017 deadline, you can do so by selecting an option below.
If the Scheme is approved at a General Meeting and Court Meeting both to be held on 23 October 2017 and a Court Hearing on 31 October 2017 it will become effective on 1 November 2017 with the resulting Shares expected on or around 2 November 2017 and resulting cash expected on or around 14 November 2017.
Full details of this event will be sent to Qualifying Hargreaves Lansdown clients by either post or secure message. Please note that any instruction you give must be based on the full details provided in the letter and not on the summary information outlined above.

×
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
82.00p
Trade high:
82.25p
Year high:
87.50p
Market capitalisation
Market cap.
:
£138.68 million
Previous close:
82.00p
Trade low:
81.75p
Year low:
37.50p
P/E ratio:
1.35
Previous:
0.25p (0.30%)
Previous:
0.25p
Volume:
1,559,575
Dividend yield:
n/a
EMS:
5,000
Data delayed by at least 15 minutes.

Performance

1 week 1W 2.53% 1 year 1Y 97.89%
1 month 1M 5.65% 2 years 2Y 29.42%
3 months 3M 48.19% 3 years 3Y n/a
6 months 6M 100.92% 5 years 5Y n/a

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Fundamental data

Year ending: 31/01/2017 31/01/2016
Revenue (£m) 88.77 69.99
Profit before tax (£m) (10.85) 6.17
Adjusted EPS (p): 60.83 7.40
P/E ratio 0.80 10.10
PEG n/a n/a
EPS growth (%) 722.00 (24.00)

Values are quoted in the stock's local currency: British pound

All fundamental data

Recent dividends paid or declared by Quantum Pharma plc:

Type Ex-div date Payment date Amount
Final 20/10/2016 07/11/2016 1.00p
Interim 29/10/2015 20/11/2015 0.50p
Final 16/07/2015 07/08/2015 0.25p

This data is provided by Digital Look. HL accepts no responsibility for its accuracy and you should independently check data before making any investment decision.

Full dividend history

Five years' total annual Quantum Pharma plc dividends:

Financial
year end
Dividend
yield
Dividend
cover
Total dividend
paid
31/01/2017 n/a n/a n/a
31/01/2016 2.00% 4.93 1.50p
31/01/2015 0.30% 38.80 0.25p
30/11/-0001 n/a 4.87 n/a

All dividend data is calculated excluding any special dividends. Historical dividends may be adjusted to reflect any subsequent rights issues and corporate actions.

Full dividend history

Open an easy to manage, low cost dealing account in less than 5 minutes

Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.

More about the Fund & Share Account

Important Documents

There are no documents available for this stock.

Broker forecasts

Broker recommendations for this stock are not available.

Time / date Time Buy / sell Type Volume Price Value
×

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. 'Broker forecast' and 'Recent trades' provided by MoneyAM. News and fundamental data provided by Digital Look.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.